Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients

This publication has 30 references indexed in Scilit:

• Intensive outpatient adjuvant therapy for breast cancer: results of dose escalation and quality of life.
  Journal of Clinical Oncology, 1996
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?
  The Lancet, 1996
• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Factors affecting treatment decisions for a life-threatening illness: The case of medical treatment of breast cancer
  Social Science & Medicine, 1991
• West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes
  British Journal of Cancer, 1989
• Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results
  European Journal of Cancer and Clinical Oncology, 1989
• Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast Cancer
  New England Journal of Medicine, 1989
• Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast Cancer
  New England Journal of Medicine, 1989
• A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative Tumors
  New England Journal of Medicine, 1989